share_log

中国再生医学公布中期业绩 净利1276.2万港元同比增长4.74倍

China Regenerative Medicine announced interim results, net profit of HK$127.62 million, up 4.74 times year-on-year

新浪港股 ·  Aug 14, 2023 19:21

China Regenerative Medicine (08158) announced interim results for 2023 with earnings of about HK $100m, an increase of 16.04 per cent year-on-year, net profit of HK $12.762 million, a year-on-year increase of 4.74per cent, and earnings per share of HK $0.447.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment